DrugPatentWatch Database Preview

Details for Patent: 8,936,800

« Back to Dashboard

Which drugs does patent 8,936,800 protect, and when does it expire?

Patent 8,936,800 protects EPIDUO and EPIDUO FORTE and is included in two NDAs.

This patent has thirty patent family members in twenty-two countries.

Summary for Patent: 8,936,800

Title:	Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Abstract:	Dermatological/cosmetic compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise, in a physiologically acceptable medium, (i) at least one dispersed retinoid, (ii) dispersed benzoyl peroxide, in free or encapsulated form, and (iii) at least one pH-independent gelling agent, selected from the group consisting of (a) polyacrylamide gelling agents, (b) gelling agents which are acrylic polymers coupled to hydrophobic chains, (c) modified starch gelling agents, and mixture thereof, said composition maintaining good chemical stability of (i) and (ii) without their degradation over time at a temperature of between 4.degree. C. and 40.degree. C.
Inventor(s):	Orsoni; Sandrine (Mandelieu, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee:	Galderma Research & Development (Biot, FR)
Application Number:	13/660,831
Patent Claim Types: see list of patent claims	Use; Composition; Compound;

Drugs Protected by US Patent 8,936,800

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Galderma Labs Lp	EPIDUO	adapalene; benzoyl peroxide	GEL;TOPICAL	022320-001	Dec 8, 2008	AB	RX	Yes	Yes			Y			TREATMENT OF ACNE
Galderma Labs	EPIDUO FORTE	adapalene; benzoyl peroxide	GEL;TOPICAL	207917-001	Jul 15, 2015		RX	Yes	Yes			Y			TREATMENT OF ACNE

Foreign Priority and PCT Information for Patent: 8,936,800

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
France	01 16747	Dec 21, 2001

Non-Orange Book US Patents Family Members for Patent 8,936,800

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,105,618	Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
8,241,649	Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
9,814,690	Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
7,820,186	Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

International Patents Family Members for US Patent 8,936,800

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	038026
Austria	347354
Australia	2002364437
Australia	2008246274